Novo Nordisk A/S


Novo Nordisk is a global healthcare company dedicated to defeating diabetes and other serious chronic diseases. The company focuses on research, development, and manufacturing of medicines, with a strong emphasis on sustainability, innovation, and corporate governance. It is committed to long-term success by creating shared value for society and investors, guided by its values and the Novo Nordisk Way.

Industries

biotechnology
health-care
medical
pharmaceutical

Nr. of Employees

Very Large (1000+)

Novo Nordisk A/S


Products

R&D pipeline (portfolio of therapeutics in development)

A portfolio of discovery and development-stage therapeutic assets focused on chronic diseases and rare conditions.


Services

Compound sharing and research partnering

Program to share compounds and collaborate with external research partners for preclinical research and early development.

Healthcare professional digital portals

Country-specific online portals providing product and disease resources for healthcare professionals.

Pharmacovigilance and adverse event reporting

Channels for patients and healthcare professionals to report side effects and product issues for investigation.

Clinical trial platform and recruitment

Global platform to support clinical trial operations, site identification and participant recruitment.

Patient support and local customer care

Localized contact points for patient inquiries, product availability and usage guidance.

Expertise Areas

  • Clinical trial management
  • Regulatory affairs and submissions (European focus)
  • Pharmacovigilance and safety surveillance
  • Drug discovery and translational research
  • Show More (6)

Key Technologies

  • Phase III clinical trial execution
  • Regulatory dossier preparation and submission (EMA)
  • Pharmacovigilance/adverse event reporting systems
  • Digital portals for healthcare professionals
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.